Diligence memo · auto-generated · as of July 2, 2026

Monteris Medical US, Inc.

Monteris Medical US, Inc. looks fair against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Monteris Medical US, Inc. operates in Healthtech, based in Minnetonka.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Monteris Medical US, Inc. has raised $83M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $27M on 2017-05-17.

Most recent recorded round closed around 2022-09-02.

Valuation (modeled)modeled

Provath models Monteris Medical US, Inc. at approximately $168M (range $32M–$427M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.02× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era. Within the normal band (102% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 13 months.

Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 1.5× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 95% of Healthtech peers (2138 compared).

Modeled value ranks above 85% of those peers.

Closest niche peers: Casana Care, Inc., Mendel Health Inc., Bicycle Health Inc., Brave Health, Inc., Flume Health, Inc..

Peoplefiled

17 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.